EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: a case report. (Q46484941)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: a case report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Aglaya G Iyevleva

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Alexey V Novik

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Evgeny N Imyanitov

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

14 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

548-550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

EGFR mRNA is upregulated, but somatic mutations of the gene are hardly found in renal cell carcinoma in Japanese patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

Multifaceted dysregulation of the epidermal growth factor receptor pathway in clear cell sarcoma of the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

Thymic carcinoma with epidermal growth factor receptor gene mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

Molecular-based choice of cancer therapy: realities and expectations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

Patterns of somatic mutation in human cancer genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

Timeline: Chemotherapy and the war on cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.03.022

10.1016/J.UROLONC.2008.03.022

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18625569%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference